Platinum Equity Agrees to Buy DMS Health Technologies

David Rosenfeld | | Radiology Business | Business Intelligence
Platinum Equity said today it had signed an agreement to acquire DMS Health Technologies from Otter Tail Corporation, based on a company press release. The purchase, which is still subject to regulatory approval, marks one of the equity firm’s largest forays into the medical imaging field. DMS provides diagnostic imaging solutions to hospitals, clinics and other healthcare providers. Platinum has purchased roughly 130 companies since 1995 covering a wide range of industries including entertainment, manufacturing and IT services and software. “Today signifies an important and exciting day in DMS Health Technologies’ future,” said DMS Health Technologies CEO Paul Wilson based on the release. “Platinum Equity’s support will allow us to take the next step in our business development. Platinum’s unique approach to providing operational expertise will serve as a competitive advantage and take DMS Health Technologies to the next level.”

David Rosenfeld

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.